FIELD: medicine.
SUBSTANCE: invention refers to biotechnology and can be used for screening of compounds with properties of agonists or antagonists of leptin receptor. There is disclosed method for detecting leptin receptor definition that provides contact of a candidate compound and cells expressing after contransfection with two expressing vectors, respectively, two fused proteins, one of which consists of a short isoform of leptin receptor (OBRs) and an energy donor protein (preferentially luciferase), and the second - of OBRs and an energy acceptor protein (preferentially GFP or its mutant form); measurement of energy transfer (BRET) between the fused proteins; comparison of its value to the relevant indicator measured in the same system, however without tested compound, and estimated result where higher energy transfer indicates binding of the candidate compound-candidate with leptin receptor. Prospective application of the invention is related to development of the preparations for prevention or treatment of disease wherein leptin or its receptor are involved.
EFFECT: development of effective method for detecting leptin receptor ligands.
4 cl, 15 dwg, 3 ex
Title |
Year |
Author |
Number |
METHOD OF PRODUCING SIALYLATED OLIGOSACCHARIDES |
2007 |
|
RU2473695C2 |
SOLUBLE POLYPEPTIDE FRACTION OF PROTEIN LAG-3, METHOD OF PREPARING, THERAPEUTICAL COMPOSITION, ANTIBODY |
1995 |
- For Florans
- Ehrsen T'Erri
- Juar Bertran
- Triebel' Frederik
|
RU2178306C2 |
ANTI-CXCR4 ANTIBODIES FOR TREATMENT OF HIV INFECTION |
2010 |
|
RU2573902C2 |
ANTI-CXCR4 ANTIBODIES AND USING THEM FOR TREATING CANCER |
2009 |
- Klinger-Amur Kristin
- Gren'E-Kossanel' Veronik
|
RU2573897C2 |
ANTIBODIES TO BTN3A AND THEIR USE IN THE TREATMENT OF CANCER OR INFECTIOUS DISEASES |
2019 |
- Truneh, Alemseged
- Olive, Daniel
- Pasero, Christine
- De Gassart, Aude
|
RU2800726C2 |
POLYNUCLEOTIDE MODULATING CANCER CELL PROLIFERATION (VARIANTS), POLYPEPTIDE, MONOCLONAL ANTIBODY, EXPRESSION VECTOR, HOST CELL, PHARMACEUTICAL AGENT FOR TREATMENT OF PROLIFERATIVE DISEASE, PHARMACEUTICAL COMPOSITION, POLYPEPTIDE USES IN PHARMACEUTICAL AGENT PRODUCTION |
2002 |
- Ferrandi Ehrik
- Kamara I Ferrer Khose-Antonio
- Martine Zhan
- Tjur'O Kristof
|
RU2307666C2 |
ANTIBODIES SPECIFIC TO BTN2 AND THEIR APPLICATIONS |
2018 |
- Olive, Daniel
- Pasero, Christine
|
RU2794996C2 |
BTN2-SPECIFIC ANTIBODIES AND USE THEREOF |
2020 |
- Foucher, Etienne
- Cano, Carla
- Le, Kieu Suong
- Pasero, Christine
- Olive, Daniel
|
RU2821703C2 |
HUMANISED ANTI-CXCR4 ANTIBODIES FOR TREATING CANCER |
2011 |
- Klinger-Amur Kristin
- Zhuanno Aleksandra
- Grene-Kossanel Veronik
- Berger Sven
|
RU2595394C2 |
RECOMBINANT LENTIVIRAL VECTOR, HOST CELL TRANSDUCED WITH LENTIVIRAL VECTOR, METHODS FOR TRANSDUCTION AND USES THEREOF |
2002 |
- Trono Did'E
- Viznerovich Matsej
|
RU2305708C2 |